Point72 Hong Kong’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,951
| Closed | -$652K | – | 1767 |
|
|
2022
Q1 | $652K | Buy |
6,951
+4,331
| +165% | +$406K | 0.02% | 273 |
|
|
2021
Q4 | $223K | Buy |
+2,620
| New | +$223K | 0.01% | 451 |
|
|
2021
Q3 | – | Sell |
-17,877
| Closed | -$1.74M | – | 1681 |
|
|
2021
Q2 | $1.74M | Buy |
+17,877
| New | +$1.74M | 0.06% | 186 |
|
|
2021
Q1 | – | Sell |
-8,107
| Closed | -$777K | – | 1540 |
|
|
2020
Q4 | $777K | Sell |
8,107
-6,281
| -44% | -$602K | 0.04% | 261 |
|
|
2020
Q3 | $1.38M | Buy |
+14,388
| New | +$1.38M | 0.15% | 157 |
|
|
2020
Q2 | – | Sell |
-446
| Closed | -$39K | – | 1328 |
|
|
2020
Q1 | $39K | Sell |
446
-2,056
| -82% | -$180K | 0.02% | 404 |
|
|
2019
Q4 | $269K | Buy |
2,502
+546
| +28% | +$58.7K | 0.06% | 254 |
|
|
2019
Q3 | $176K | Buy |
+1,956
| New | +$176K | 0.05% | 327 |
|
|
2019
Q2 | – | Sell |
-1,434
| Closed | -$126K | – | 1302 |
|
|
2019
Q1 | $126K | Buy |
+1,434
| New | +$126K | 0.05% | 298 |
|
|
2018
Q4 | – | Sell |
-492
| Closed | -$60K | – | 1093 |
|
|
2018
Q3 | $60K | Buy |
+492
| New | +$60K | 0.02% | 426 |
|
|
2018
Q2 | – | Sell |
-233
| Closed | -$19K | – | 1093 |
|
|
2018
Q1 | $19K | Buy |
+233
| New | +$19K | 0.01% | 625 |
|
|
2017
Q1 | – | Sell |
-7,267
| Closed | -$281K | – | 886 |
|
|
2016
Q4 | $281K | Buy |
7,267
+6,267
| +627% | +$242K | 0.28% | 101 |
|
|
2016
Q3 | $51K | Buy |
+1,000
| New | +$51K | 0.03% | 467 |
|